New Feature: See Wall Street analyst ratings directly on Finviz charts for deeper context into price action.

Learn More

Here's What Key Metrics Tell Us About Ryan Specialty (RYAN) Q4 Earnings

By Zacks Equity Research | February 12, 2026, 6:30 PM

Ryan Specialty Group (RYAN) reported $751.21 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 13.2%. EPS of $0.45 for the same period compares to $0.45 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $777.88 million, representing a surprise of -3.43%. The company delivered an EPS surprise of -9.4%, with the consensus EPS estimate being $0.50.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Ryan Specialty performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenue- Fiduciary investment income: $13.17 million versus $14.25 million estimated by three analysts on average.
  • Revenue- Net commissions and fees: $738.05 million versus $771.1 million estimated by three analysts on average.
  • Revenue- Net commissions and fees- Binding Authority: $84.05 million versus the two-analyst average estimate of $85.81 million.
  • Revenue- Net commissions and fees- Underwriting Management: $268.31 million compared to the $276.94 million average estimate based on two analysts.
  • Revenue- Net commissions and fees- Wholesale Brokerage: $385.69 million versus $406.7 million estimated by two analysts on average.

View all Key Company Metrics for Ryan Specialty here>>>

Shares of Ryan Specialty have returned -14.2% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Ryan Specialty Holdings Inc. (RYAN): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News